Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06094543

Improving Overactive Bladder Treatment Access and Adherence

Improving Overactive Bladder Treatment Access and Adherence Through Personalized Behavioral Modifications and Mobile Technology-Based Interventions

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Stanford University · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

Overactive bladder (OAB) and urinary incontinence (UI) are chronic debilitating and embarrassing conditions that affect 33 million Americans. Yet, both are underdiagnosed and undertreated with significant financial and health-related consequences. OAB syndrome is characterized by urinary urgency, with and without urinary incontinence, urinary frequency, and nocturia. Evidence-based treatments are available, including behavioral therapy, pharmacotherapy, and minimally invasive procedures. Diagnosis and treatment are also associated with improvement in urinary symptoms and overall quality of life (QOL).3 However, 70-80% of treated patients will discontinue use of therapy in the first year due to one of several factors (e.g., cost, tolerability, inadequate effect). In addition, only 4.7% progress to advanced therapies suggesting undertreatment for those that need it most. Vulnerable populations are especially at risk, as therapy utilization are lowest among older, lower income, and/or minority groups. Poor access, insufficient patient education regarding disease chronicity, expected outcomes, costs, and potential side effects lead to unrealistic patient perceptions about therapy. This leads to suboptimal therapy duration, poor treatment efficacy, adherence, and undertreatment. The study aims to evaluate a tailored patient-centered tool to begin the treatment process.

Conditions

Interventions

TypeNameDescription
BEHAVIORALPatient Engagement Tool8 week daily patient education and engagement tool

Timeline

Start date
2024-11-01
Primary completion
2026-08-01
Completion
2026-12-01
First posted
2023-10-23
Last updated
2025-11-26

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06094543. Inclusion in this directory is not an endorsement.